Estonia-based Better Medicine raises nearly $7 million to expand its radiology AI solution and enter the U.S. market.
Key Details
- 1Better Medicine is an AI startup focused on radiology, founded in 2020 in Estonia.
- 2The company raised an additional $1.2 million, bringing total funding close to $7 million.
- 3Its flagship product, BMVision Kidney, detects malignant lesions from CT scans.
- 4Better Medicine currently operates in six countries and aims to expand to the U.S.
- 5The new funding will support further European growth and preparations for U.S. market entry.
Why It Matters
Better Medicine's growth and international expansion reflect ongoing investor confidence in radiology AI. Tools that integrate into radiologist workflows and target specific organs, such as the kidney, could enhance cancer detection and address radiologist shortages globally.
Source
Radiology Business
Related News
•Radiology Business
Cigna Expands Nationwide Coverage for CT Imaging AI Tools
Cigna will reimburse for CT-based plaque analysis AI software for millions of members nationwide.
•AuntMinnie
AI Model Produces Clinically Acceptable Chest X-Ray Reports
A South Korean study finds that AI-generated chest x-ray reports are nearly as clinically acceptable as radiologist-written reports under standard criteria.
•AI in Healthcare
Joint Commission Issues AI Guidance; Radiology AI Advancements Highlighted
Joint Commission releases AI safety guidance while major advances surface in predictive and radiology AI models.